Introduction to ICA-2021
The Annual International Congress of Antibodies (ICA), initiated from 2009, had been successfully organized in Beijing, Hangzhou Dalian and Nanjing, attracted more than 3,500 participants from 60 countries. ICA series congresses contribute to offering professionals in the field of antibody a multidisciplinary informative cooperative platform, and it has been the most definite and grand Antibody event in Asia. The ICA-2021 will be held during September 25-27, 2021 at Dalian International Conference Center, China.
Programmed Chapters at a Glance
Main conference
Plenary Forum: New Horizon of Antibody Innovation
Nexus 1: Future Landscape of Therapeutic Antibody Discovery
Nexus 2: New Landscape of Antibody Discovery Technology
Nexus 3: Most Charming Targets for Therapeutic Antibody Designs
Nexus 4: Antibody-ADCs and Multi-Specific Antibodies as Next Big Things
Nexus 5: Antibodies as Diagnostic Biomarkers
Nexus 6: Alternative Applications of Versatile Antibodies
Nexus 7: Facinating MABs from Non-Human Primates
Nexus 8: Smart Antibody DDS
Nexus 9: Antibody Clinical Trials
Nexus 10: Antibody Engineering and Bioanalysis
Nexus 11: Biosimilars and Biosuperiors of Antibody Therapy
Nexus 12: Antibody Custom Services
Renowned Speakers of Previous Events
 |
Dr. Bruce A. Beutler, Professor, UT Southwestern, USA |
 |
Dr. Tim Hunt, Emeritus Group Leader, Clare Hall Laboratories, UK |
 |
Dr. Steven J. Swanson, Senior Vice President, ImmunoCellular Therapeutics, Ltd., USA |
 |
Dr. Mitchell Ho, Senior Investigator, National Cancer Institute, NIH, USA |
 |
Dr. Thomas J. Webster, Art Zafirpoulo Chair, Chair Department of Chemical Engineering, Northeastern University, USA |
 |
Ms. Robin Barbour, Head, Prothena Corporation, USA |
 |
Dr. Jing Li, Senior Vice President, WuXi Biologics, China |
 |
Dr. William R. Alley, Jr., Senior Scientist, Waters Corp., USA |
 |
Dr. Eric Risser, Senior Vice President, MacroGenics, Inc., USA |
 |
Dr. Madi R. Madiyalakan, CEO, Quest PharmaTech Inc., Canada |
 |
Dr. Weikang Tao, Vice President and CEO of R&D Center, Jiangsu Henrui Medicine Co., Ltd., China |
 |
Dr. Esther Una Cidon, Professor, Royal Bournemouth Hospital, UK |
 |
Ms. Ningling Wang, Managing Partner, Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, China |
 |
Dr. Z. Ying Li, Partner, Steptoe & Johnson LLP, USA |
 |
Dr. Weiping Shao, Director, Regeneron Pharmaceuticals, Inc., USA |
 |
Dr. Lidia Anna Retkowska-Mika, Director, Office for Registration of Medicinal Products, Medical Devices and Biocides, Poland |
 |
Dr. Ulrich Storz, Senior Partner, Michalski•Hüttermann & Partner, Germany |
 |
Dr. George Lovrecz, Adjunct Professor, RMIT University, Australia |
 |
Ms. Xingmei Tan, Senior Engineer, Abcam(Hangzhou)Biotechnology Co. Ltd., China |
 |
Dr. Mark I. Fitchmun, President and Senior Advisor, Somatek. Inc., USA |
 |
Dr. Nirmesh Shah, Director, Apobiologix, USA |
 |
Dr. Matthew F. Heil, Chief Scientific Officer, Curemark LLC, USA |
 |
Dr. Carole Schante, Principal Scientist, Novartis, Switzerland |
 |
Dr. Marcus Mreyen, Director, Protagen Protein Services GmbH, Germany |
 |
Dr. Candida Fratazzi, President, BBCR Consulting, USA |
 |
Dr. Shawn Guse, President and CEO, Intuitive Biosciences, USA |
 |
Dr. Abhishek Saharia, Director, DiscoveRx Corporation, USA |
 |
Dr. David Franco, Head, GSK Vaccines, Belgium |
 |
Dr. Hui Zhao, Principal Scientist, Agensys, USA |
 |
Dr. Xianbin Yang, Director of R & D, AM Biotechnologies, USA |
 |
Dr. Steve Xiaofeng Yu, Director, Cyagen Biosciences, Inc, China |
 |
Dr. Patrick Liu, Vice President, Teva Pharmaceuticals Ltd., USA |
 |
Dr. Martin Welschof, CEO, Opsona Therapeutics Ltd, Ireland |
 |
Dr. Matthias Germer, Senior Director, Biotest AG, Germany |
 |
Dr. William L. Klein, Professor, University of California - Los Angeles, USA |
 |
Dr. Kevin Heyries, Co-Founder, AbCellera, Canada |
|
Sponsors |
Exhibitors |
|
● ICA-2021 is one of the most effective international marketing platforms in the field of life science and biomedicine, which offers a wide range of sponsoring categories for branding and highlighting your company in order to achieve the best publicity. |
● The exhibition will be visited by participants of the conference it means by your authentic target group from China and other countries. |
| More | More |
Speaking Proposals Are Now Being AcceptedCall for Exhibitors and SponsorsCall for Collaborative
ICA-2021 will be celebrated at Dalian International Conference Center, China
BIT Congress Inc.
 |
©2009-2021 All rights reserved by BIT Congress Inc. Contact Us: Tel: 0086-411-84799609, Fax: 0086-411-84799629 |